No Data
No Data
Express News | Dogwood Therapeutics up 25% After Resuming Trading
Trading Halt: Halt Status Updated at 8:50:00 AM ET: Quotation Resumption: News and Resumption Times
H.C. Wainwright Maintains Virios Therapeutics(VIRI.US) With Hold Rating, Maintains Target Price $5
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Maintaining Hold on Virios Therapeutics Amid Merger and Clinical Development Uncertainties
Stocks in the United States | virios therapeutics surged more than 33% pre-market, has reached a clear merger agreement with Wex Pharmaceuticals.
Gelonghui October 8th | Virios Therapeutics soared more than 33% to $0.183 before the market opened. The company announced on Monday that it has reached a definitive stock trade agreement to merge with another subsidiary of Kangyi Life Sciences International Limited company, Wex Pharmaceuticals, in an all-stock trade deal. Virios will be renamed Dogwood Therapeutics starting from Wednesday.
No Data
No Data